Prenetics Global Ltd. (PRE)
21.84
-0.16
(-0.73%)
USD |
NASDAQ |
Oct 09, 16:00
21.76
-0.08
(-0.37%)
After-Hours: 20:00
Prenetics Global Net Income (Quarterly) : -9.088M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.088M |
| March 31, 2026 | -27.34M |
| December 31, 2025 | -28.41M |
| September 30, 2025 | -6.788M |
| June 30, 2025 | -9.295M |
| March 31, 2025 | -6.072M |
| December 31, 2024 | -13.34M |
| September 30, 2024 | -9.863M |
| June 30, 2024 | -8.898M |
| March 31, 2024 | -9.025M |
| December 31, 2023 | -18.59M |
| Date | Value |
|---|---|
| September 30, 2023 | -11.99M |
| June 30, 2023 | -18.38M |
| March 31, 2023 | -13.71M |
| December 31, 2022 | -13.10M |
| September 30, 2022 | -17.52M |
| June 30, 2022 | -149.02M |
| March 31, 2022 | 7.192M |
| December 31, 2021 | -85.74M |
| September 30, 2021 | -80.41M |
| June 30, 2021 | -9.775M |
| March 31, 2021 | -0.0055M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Global Cord Blood Corp. | -- |
| Exlites Holdings International, Inc. | -0.0039M |
| Xcelerate, Inc. | -0.0542M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Fresenius SE & Co. KGaA | 463.92M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 46.49M |
| Total Expenses (Quarterly) | 55.58M |
| EPS Diluted (Quarterly) | -0.5203 |
| Enterprise Value | 256.60M |
| Gross Profit Margin (Quarterly) | 64.97% |
| Profit Margin (Quarterly) | -19.55% |
| Earnings Yield | -19.08% |
| Normalized Earnings Yield | -14.25 |